Expression and characterization of SARS-CoV-2 spike proteins | Nature Protocols
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition - ScienceDirect
Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants | Journal of the American Chemical Society
Purifying bispecific antibodies in a single step | Cytiva
Optimized expression and purification of a soluble BMP2 variant based on in-silico design - ScienceDirect
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6 | Nature Communications
CUTANA™ DNA Purification Kit
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants | Nature Communications
SARS-CoV-2 Neutralization Assay Kit - The Native Antigen Company
Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants | Scientific Reports
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex | Science
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses - eBioMedicine
Bispecific Antibodies: Downstream Purification - BioProcess InternationalBioProcess International
Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle | PNAS
Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples - ScienceDirect
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro - eBioMedicine
Controlling the SARS-CoV-2 spike glycoprotein conformation | Nature Structural & Molecular Biology
Frontiers | Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody
Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2 | Cell Discovery
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential - ScienceDirect
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
Designed SARS‐CoV‐2 receptor binding domain variants form stable monomers - Klausberger - 2022 - Biotechnology Journal - Wiley Online Library
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
